Yu SC, Chen HH, Lin PY (2024) Necrosis in lymph nodes and their differential diagnoses: application of reticulin staining. Virchows Arch 485:137–142. https://doi.org/10.1007/s00428-023-03588-5.
Article PubMed CAS Google Scholar
Switzer RC (2000) Application of Silver Degeneration Stains for Neurotoxicity Testing. Toxicol Pathol 28:70–83. https://doi.org/10.1177/019262330002800109
Article PubMed CAS Google Scholar
Munari E, Scarpa A, Cima L, Pozzi M, Pagni F, Vasuri F, et al (2024) Cutting-edge technology and automation in the pathology laboratory. Virchows Arch 484:555–566. https://doi.org/10.1007/s00428-023-03637-z
Iezzoni JC (2018) Diagnostic histochemistry in hepatic pathology. Semin Diagn Pathol 35:381–389. https://doi.org/10.1053/j.semdp.2018.10.003
Patil A, Salvatori R, Smith L, Jenkins SM, Cannon A, Hartley CP, et al (2023) Artificial intelligence‐based reticulin proportionate area – a novel histological outcome predictor in hepatocellular carcinoma. Histopathology 83:512–525. https://doi.org/10.1111/his.15001
Jarzembowski J, Lloyd R, McKeever P (2007) Type IV Collagen Immunostaining Is a Simple, Reliable Diagnostic Tool for Distinguishing Between Adenomatous and Normal Pituitary Glands. Arch Pathol Lab Med 131:931–935. https://doi.org/10.5858/2007-131-931-TICIIA
Article PubMed CAS Google Scholar
Kuşku Çabuk F, Sar M, Canoğlu D, Dural C, Güneş ME (2020) Reticulin staining pattern in the differential diagnosis of benign parathyroid lesions. J Endocrinol Invest 43:1571–1576. https://doi.org/10.1007/s40618-020-01239-z
Article PubMed CAS Google Scholar
Hu X, He S, Jiang X, Wei P, Zhou X, Shi Z, et al (2023) Reticular fibre structure in the differential diagnosis of parathyroid neoplasms. Diagn Pathol 18:79. https://doi.org/10.1186/s13000-023-01368-y
Article PubMed PubMed Central CAS Google Scholar
Volante M, Bollito E, Sperone P, Tavaglione V, Daffara F, Porpiglia F, et al (2009) Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology 55:535–543. https://doi.org/10.1111/j.1365-2559.2009.03423.x
Duregon E, Fassina A, Volante M, Nesi G, Santi R, Gatti G, et al (2013) The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. Am J Surg Pathol 37:1433–1440. https://doi.org/10.1097/PAS.0b013e31828d387b
Lopez-Nunez O, Virgone C, Kletskaya IS, Santoro L, Giuliani S, Okoye B, et al (2024) Diagnostic Utility of a Modified Reticulin Algorithm in Pediatric Adrenocortical Neoplasms. Am J Surg Pathol 48:309–316. https://doi.org/10.1097/PAS.0000000000002174
Violon F, Bouys L, Berthon A, Ragazzon B, Barat M, Perlemoine K, et al (2023) Impact of Morphology in the Genotype and Phenotype Correlation of Bilateral Macronodular Adrenocortical Disease (BMAD): A Series of Clinicopathologically Well-Characterized 35 Cases. Endocr Pathol 34:179–199. https://doi.org/10.1007/s12022-023-09751-7
Article PubMed CAS Google Scholar
Violon F, Bouys L, Vaduva P, Chansavang A, Vaquier L, Letourneur F, et al (2024) Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological Subgroups. Endocr Pathol 35:194–206. https://doi.org/10.1007/s12022-024-09824-1
Article PubMed CAS Google Scholar
WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. Lyon (France): International Agency for Research on Cancer; 2025. (WHO classification of tumours series, 5th ed.; vol. 10). https://publications.iarc.who.int/645
Velasco ME, Sindely SD, Roessmann U (1977) Reticulum stain for frozen-section diagnosis of pituitary adenomas: Technical note. J Neurosurg 46:548–550. https://doi.org/10.3171/jns.1977.46.4.0548
Article PubMed CAS Google Scholar
Noh S, Kim SH, Cho NH, Kim SH (2015) Rapid Reticulin Fiber Staining Method is Helpful for the Diagnosis of Pituitary Adenoma in Frozen Section. Endocr Pathol 26:178–184. https://doi.org/10.1007/s12022-015-9370-y
Kleinschmidt-DeMasters BK, Lopes MBS, Prayson RA (2015) An Algorithmic Approach to Sellar Region Masses. Arch Pathol Lab Med 139:356–372. https://doi.org/10.5858/arpa.2014-0020-OA
Article PubMed CAS Google Scholar
Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ (2022) Overview of the 2022 WHO Classification of Parathyroid Tumors. Endocr Pathol 33:64–89. https://doi.org/10.1007/s12022-022-09709-1
Cetani F, Marcocci C, Torregrossa L, Pardi E (2019) Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer 26:R441–R464. https://doi.org/10.1530/ERC-19-0135
Article PubMed CAS Google Scholar
Weiss LM, Medeiros LJ, Vickery AL (1989) Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202–206. https://doi.org/10.1097/00000478-198903000-00004
Article PubMed CAS Google Scholar
Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, et al (2002) Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26:1612–1619. https://doi.org/10.1097/00000478-200212000-00009
Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, et al (2015) Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas. Hum Pathol 46:404–410. https://doi.org/10.1016/j.humpath.2014.11.015
Bisceglia M, Ludovico O, Di Mattia A, Ben-Dor D, Sandbank J, Pasquinelli G, et al (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12:231–243. https://doi.org/10.1177/106689690401200304
Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, et al (2021) Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol 110:50–61. https://doi.org/10.1016/j.humpath.2020.10.001
Wieneke JA, Thompson LDR, Heffess CS (2003) Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol 27:867–881. https://doi.org/10.1097/00000478-200307000-00001
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A (2022) Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol 33:90–114. https://doi.org/10.1007/s12022-022-09704-6
Article PubMed CAS Google Scholar
Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al (2017) Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell 31:181–193. https://doi.org/10.1016/j.ccell.2017.01.001
Article PubMed PubMed Central CAS Google Scholar
Juhlin CC (2021) Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry. Endocr Pathol 32:228–244. https://doi.org/10.1007/s12022-021-09675-0
Article PubMed PubMed Central Google Scholar
Juhlin CC, Mete O (2024) Hot Trends in Pheochromocytoma and Paraganglioma: Are We Getting Closer to Personalized Dynamic Prognostication? Turk Patoloji Derg 40:143–148. https://doi.org/10.5146/tjpath.2024.13681
Comments (0)